Growth Metrics

Pfizer (PFE) Tax Rate Growth (3y) (2012 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Novartis Ag 107,124,802.25 Bn 107,124,802.25 Bn -
2 Eli Lilly 969.00 Bn 963.72 Bn 16.22 Bn
3 Johnson & Johnson 539.46 Bn 517.41 Bn 15.96 Bn
4 AbbVie 376.92 Bn 367.57 Bn 10.78 Bn
5 Merck 285.00 Bn 279.35 Bn 12.09 Bn
6 Amgen 177.58 Bn 165.55 Bn 5.87 Bn
7 Gilead Sciences 163.22 Bn 155.50 Bn 5.52 Bn
8 Pfizer 145.86 Bn 133.09 Bn -1.21 Bn
9 Bristol Myers Squibb 111.90 Bn 101.44 Bn 8.07 Bn
10 Gsk 88.34 Bn 83.66 Bn -

Historic Data

Download Data 🔒
DateValue
Mar 29, 2026 314.00
Sep 28, 2025 -1,043.00
Jun 29, 2025 -908.00
Mar 30, 2025 -1,974.00
Sep 29, 2024 914.00
Jun 30, 2024 11,394.00
Mar 31, 2024 -563.00
Oct 1, 2023 8,964.00
Jul 2, 2023 -1,707.00
Apr 2, 2023 -123.00
Oct 2, 2022 -2,445.00
Jul 3, 2022 3,581.00
Apr 3, 2022 293.00
Oct 3, 2021 -576.00
Jul 4, 2021 185.00
Apr 4, 2021 72.00
Sep 27, 2020 -8,116.00
Jun 28, 2020 -543.00
Mar 29, 2020 -815.00
Dec 31, 2019 2,340.00
Sep 29, 2019 1,288.00
Jun 30, 2019 -3,649.00
Mar 31, 2019 -439.00
Dec 31, 2018 -3,648.00
Sep 30, 2018 -1,944.00
Jul 1, 2018 -1,126.00
Apr 1, 2018 -943.00
Dec 31, 2017 -121,849.00
Oct 1, 2017 -512.00
Jul 2, 2017 -766.00
Apr 2, 2017 34.00
Dec 31, 2016 -1,224.00
Oct 2, 2016 -1,204.00
Jul 3, 2016 -1,887.00
Apr 3, 2016 -1,537.00
Dec 31, 2015 2,427.00
Sep 27, 2015 2,755.00
Jun 28, 2015 -266.00
Mar 29, 2015 -629.00
Dec 31, 2014 -386.00
Sep 28, 2014 -894.00
Jun 29, 2014 -290.00
Mar 30, 2014 -823.00
Dec 31, 2013 21,894.00
Sep 29, 2013 -1,189.00
Jun 30, 2013 -423.00
Mar 31, 2013 -627.00
Dec 31, 2012 -51,277.00
Sep 30, 2012 -1,090.00
Jul 1, 2012 245.00
Apr 1, 2012 96.00